AAAAAA

   
Results: 1-14 |
Results: 14
HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure
Authors: Marastoni, M Bazzaro, M Salvadori, S Bortolotti, F Tomatis, R
Citation: M. Marastoni et al., HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure, BIO MED CH, 9(4), 2001, pp. 939-945
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: Synthesis and immunological activity
Authors: Marastoni, M Bazzaro, M Micheletti, F Gavioli, R Tomatis, R
Citation: M. Marastoni et al., Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: Synthesis and immunological activity, J MED CHEM, 44(14), 2001, pp. 2370-2373
A CD4/T-4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity
Authors: Boschi, A Uccelli, L Bolzati, C Marastoni, M Tomatis, R Spisani, S Traniello, S Piffanelli, A
Citation: A. Boschi et al., A CD4/T-4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity, NUCL MED BI, 27(8), 2000, pp. 791-795
Peptide T-araC conjugates: Solid-phase synthesis and biological activity of N-4-(acylpeptidyl)-araC
Authors: Manfredini, S Marastoni, M Tomatis, R Durini, E Spisani, S Pani, A Marceddu, T Musiu, C Marongiu, ME La Colla, P
Citation: S. Manfredini et al., Peptide T-araC conjugates: Solid-phase synthesis and biological activity of N-4-(acylpeptidyl)-araC, BIO MED CH, 8(3), 2000, pp. 539-547
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope
Authors: Marastoni, M Bazzaro, M Gavioli, R Micheletti, F Traniello, S Tomatis, R
Citation: M. Marastoni et al., Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope, EUR J MED C, 35(6), 2000, pp. 593-598
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors
Authors: Balboni, G Marastoni, M Merighi, S Borea, PA Tomatis, R
Citation: G. Balboni et al., Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors, EUR J MED C, 35(11), 2000, pp. 979-988
Supra-agonist peptides enhance the reactivation of memory CTL responses
Authors: Micheletti, F Canella, A Vertuani, S Marastoni, M Tosi, L Volinia, S Traniello, S Gavioli, R
Citation: F. Micheletti et al., Supra-agonist peptides enhance the reactivation of memory CTL responses, J IMMUNOL, 165(8), 2000, pp. 4264-4271
Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors
Authors: Balboni, G Marastoni, M Merighi, S Borea, PA Tomatis, R
Citation: G. Balboni et al., Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors, ARZNEI-FOR, 50(6), 2000, pp. 507-511
Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors
Authors: Marastoni, M Bazzaro, M Bortolotti, F Tomatis, R
Citation: M. Marastoni et al., Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors, ARZNEI-FOR, 50(6), 2000, pp. 564-568
Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes
Authors: Marastoni, M Bazzaro, M Bortolotti, F Salvadori, S Tematis, R
Citation: M. Marastoni et al., Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes, EUR J MED C, 34(7-8), 1999, pp. 651-657
A single specific amino acid residue in peptide antigens is sufficient to activate memory CTL: Potential role of cross-reactive peptides in memory T cell maintenance
Authors: Reali, E Guerrini, R Marastoni, M Tomatis, R Masucci, MG Traniello, S Gavioli, R
Citation: E. Reali et al., A single specific amino acid residue in peptide antigens is sufficient to activate memory CTL: Potential role of cross-reactive peptides in memory T cell maintenance, J IMMUNOL, 162(1), 1999, pp. 106-113
The lifespan of major histocompatibility complex class I peptide complexesdetermines the efficiency of cytotoxic T-lymphocyte responses
Authors: Micheletti, F Bazzaro, M Canella, A Marastoni, M Traniello, S Gavioli, R
Citation: F. Micheletti et al., The lifespan of major histocompatibility complex class I peptide complexesdetermines the efficiency of cytotoxic T-lymphocyte responses, IMMUNOLOGY, 96(3), 1999, pp. 411-415
Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies
Authors: Micheletti, F Guerrini, R Formentin, A Canella, A Marastoni, M Bazzaro, M Tomatis, R Traniello, S Gavioli, R
Citation: F. Micheletti et al., Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies, EUR J IMMUN, 29(8), 1999, pp. 2579-2589
Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues
Authors: Marastoni, M Guerrini, R Balboni, G Salvadori, S Fantin, G Fogagnolo, M Lazarus, LH Tomatis, R
Citation: M. Marastoni et al., Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues, ARZNEI-FOR, 49(1), 1999, pp. 6-12
Risultati: 1-14 |